Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Common Share (Tables)

Net Loss Per Common Share (Tables)

14 Months Ended

Mar. 31, 2013

Reconciliation of Numerator and Denominator

A reconciliation of the numerator and denominator used in the calculation is as follows (in thousands, except per share amounts):


	Three Months Ended March 31,
	2013			2012
Numerator:
Net loss	$	(9,214	)	$	(115,533	)

Denominator:
Weighted average common shares outstanding		56,486			50,326

Net loss per share
Basic	$	(0.16	)	$	(2.30	)
Diluted	$	(0.16	)	$	(2.30	)

Warrants, Options and Purchase Rights Excluded from Computation of Diluted Net Loss Per Share

The following outstanding warrants, options and purchase rights under the Company’s 2004 Employee Stock Purchase Plan were excluded from the computation of diluted net loss per share for the periods presented because including them would have had an antidilutive effect (in thousands):


	As of March 31,
	2013		2012
Shares issuable upon exercise of warrants		11,573		13,648
Shares issuable upon exercise of stock options		6,481		3,828
Shares issuable related to the ESPP		48		42